Health Data Management July 12, 2019
Danville, Penn.-based Geisinger is teaming with an Israeli artificial intelligence vendor to better diagnose and treat patients with high-burden diseases.
Under the multi-year partnership, Geisinger’s Steele Institute for Health Innovation is working with Israel’s Medial EarlySign to develop and deploy a suite of machine learning-based solutions.
“Leveraging Geisinger’s performance as a national leader in healthcare and its culture of innovation with EarlySign’s expertise in machine learning and data analytics will enable us to identify, evaluate and intervene with high-risk patients earlier,” says Karen Murphy, executive vice president and chief innovation officer at Geisinger. “This collaboration will help us potentially save lives and improve the care we provide patients by deepening our experience with AI and identifying new ways to integrate...